• 1. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Research Brief on 4'-Fluoro-2-methoxybiphenyl-4-carboxylic acid (CAS: 1214384-09-4) in Chemical Biology and Pharmaceutical Applications

4'-Fluoro-2-methoxybiphenyl-4-carboxylic acid (CAS: 1214384-09-4) is a biphenyl derivative that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug development. This compound, characterized by its fluorine and methoxy functional groups, serves as a versatile intermediate in the synthesis of bioactive molecules. Recent studies have explored its role in the design of novel therapeutic agents, particularly in the context of inflammation, oncology, and central nervous system (CNS) disorders. This research brief synthesizes the latest findings on this compound, highlighting its chemical properties, synthetic pathways, and pharmacological potential.

The structural uniqueness of 4'-Fluoro-2-methoxybiphenyl-4-carboxylic acid lies in its biphenyl scaffold, which is known to enhance binding affinity to various biological targets. The fluorine atom at the 4' position and the methoxy group at the 2 position contribute to its electronic and steric properties, making it an attractive candidate for structure-activity relationship (SAR) studies. Recent synthetic methodologies have focused on optimizing the yield and purity of this compound, with advancements in catalytic cross-coupling reactions and green chemistry approaches. These developments are critical for scaling up production and ensuring reproducibility in pharmaceutical applications.

In the realm of drug discovery, 4'-Fluoro-2-methoxybiphenyl-4-carboxylic acid has been investigated as a key building block for the development of small-molecule inhibitors. For instance, it has been incorporated into the design of kinase inhibitors targeting aberrant signaling pathways in cancer. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the synthesis of potent BRAF V600E inhibitors, which are relevant for treating melanoma. The compound's ability to modulate protein-protein interactions (PPIs) has also been explored, with promising results in disrupting inflammatory cascades mediated by NF-κB.

Beyond oncology, this compound has shown potential in CNS drug development. Research published in ACS Chemical Neuroscience (2024) revealed its incorporation into novel analogs of serotonin receptor modulators, which exhibited improved blood-brain barrier (BBB) penetration and selectivity. These findings underscore the compound's versatility in addressing unmet medical needs in neuropsychiatric disorders. Additionally, its metabolic stability and low toxicity profile, as evidenced by in vitro and in vivo studies, further support its candidacy for preclinical development.

Despite these advancements, challenges remain in fully elucidating the compound's mechanism of action and optimizing its pharmacokinetic properties. Future research directions may include computational modeling to predict its interactions with off-target proteins and the development of prodrug strategies to enhance bioavailability. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinical applications. In conclusion, 4'-Fluoro-2-methoxybiphenyl-4-carboxylic acid represents a promising scaffold in chemical biology, with broad implications for next-generation therapeutics.

• 1184821-08-6(4-(5-Fluoro-2-methoxyphenyl)benzoic acid)
• 376592-43-7(3-(5-Fluoro-2-methoxyphenyl)benzoic acid)
• 1214349-25-3(4-(3-Fluorophenyl)-3-methoxybenzoic acid)
• 1261932-79-9(3-(2,5-Dimethoxyphenyl)-5-fluorobenzoic acid)
• 1261924-27-9(5-Fluoro-3-(2-methoxyphenyl)benzoic acid)
• 1261921-46-3(4-(3,4-Difluorophenyl)-3-methoxybenzoic acid)
• 505082-88-2(4-(4-Fluoro-2-methoxyphenyl)benzoic acid)
• 1261903-55-2(4-(4-Fluoro-3-methylphenyl)-3-methoxybenzoic acid)
• 1261905-51-4(4-(4-Fluoro-2-hydroxyphenyl)-3-methoxybenzoic acid)
• 1261907-29-2(4-(4-Fluoro-3-methoxyphenyl)-3-methoxybenzoic acid)